Sunesis Pharmaceuticals, Inc. (SNSS)
Q3 2018 Earnings Conference Call
November 05, 2018, 16:30 ET
Executives
William Quinn - SVP, Finance & Corporate Development and CFO
Dayton Misfeldt - Interim CEO & Director
Judith Fox - Chief Scientific Officer
Analysts
Marc Frahm - Cowen and Company
Hartaj Singh - Oppenheimer
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Sunesis Pharmaceuticals Third Quarter 2018 Earnings Conference Call. [Operator Instructions]. As a reminder, this call is being recorded. I would now like to introduce your host, Willie Quinn, Chief Financial Officer and Senior Vice President,